Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD

被引:141
作者
Dransfield, M. T. [1 ,2 ]
Rowe, S. M. [1 ]
Johnson, J. E. [1 ]
Bailey, W. C. [1 ]
Gerald, L. B. [1 ]
机构
[1] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA
[2] Birmingham VA Med Ctr, Birmingham, AL USA
关键词
D O I
10.1136/thx.2007.081893
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Cardiovascular disease is a major cause of death in patients with chronic obstructive pulmonary disease (COPD) and predicts hospitalisation for acute exacerbation, in-hospital death and post-discharge mortality. Although beta blockers improve cardiovascular outcomes, patients with COPD often do not receive them owing to concerns about possible adverse pulmonary effects. There are no published data about b blocker use among inpatients with COPD exacerbations. A study was undertaken to identify factors associated with b blocker use in this setting and to determine whether their use is associated with decreased in-hospital mortality. Methods: Administrative data from the University of Alabama Hospital were reviewed and patients admitted between October 1999 and September 2006 with an acute exacerbation of COPD as a primary diagnosis or as a secondary diagnosis with a primary diagnosis of acute respiratory failure were identified. Demographic data, comorbidities and medication use were recorded and subjects receiving beta blockers were compared with those who did not. Multivariate regression analysis was performed to determine predictors of in-hospital death after controlling for known covariates and the propensity to receive beta blockers. Results: 825 patients met the inclusion criteria. Inhospital mortality was 5.2%. Those receiving beta blockers (n = 142) were older and more frequently had cardiovascular disease than those who did not. In multivariate analysis adjusting for potential confounders including the propensity score, beta blocker use was associated with reduced mortality (OR = 0.39; 95% CI 0.14 to 0.99). Age, length of stay, number of prior exacerbations, the presence of respiratory failure, congestive heart failure, cerebrovascular disease or liver disease also predicted in-hospital mortality (p<0.05). Conclusions: The use of beta blockers by inpatients with exacerbations of COPD is well tolerated and may be associated with reduced mortality. The potential protective effect of beta blockers in this population warrants further study.
引用
收藏
页码:301 / 305
页数:5
相关论文
共 38 条
[1]   Mortality after hospitalization for COPD [J].
Almagro, P ;
Calbo, E ;
de Echagüen, AO ;
Barreiro, B ;
Quintana, S ;
Heredia, JL ;
Garau, J .
CHEST, 2002, 121 (05) :1441-1448
[2]   The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial [J].
Anthonisen, NR ;
Skeans, MA ;
Wise, RA ;
Manfreda, J ;
Kanner, RE ;
Connett, JE .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) :233-239
[3]   Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease [J].
Au, DH ;
Bryson, CL ;
Fan, VS ;
Udris, EM ;
Curtis, JR ;
McDonell, MB ;
Fihn, SD .
AMERICAN JOURNAL OF MEDICINE, 2004, 117 (12) :925-931
[4]   Association between inhaled β-agonists and the risk of unstable angina and myocardial infarction [J].
Au, DH ;
Curtis, JR ;
Every, NR ;
McDonell, MB ;
Fihn, SD .
CHEST, 2002, 121 (03) :846-851
[5]   The risk of myocardial infarction associated with inhaled β-adrenoceptor agonists [J].
Au, DH ;
Lemaitre, RN ;
Curtis, JR ;
Smith, NL ;
Psaty, BM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (03) :827-830
[6]   In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD - A retrospective study [J].
Chua, AP ;
Lee, KH ;
Lim, TK .
CHEST, 2005, 128 (02) :518-524
[7]  
Cleophas TJ, 2001, INT J CLIN PHARM TH, V39, P383
[8]   Outcomes following acute exacerbation of severe chronic obstructive lung disease [J].
Connors, AF ;
Dawson, NV ;
Thomas, C ;
Harrell, FE ;
Desbiens, N ;
Fulkerson, WJ ;
Kussin, P ;
Bellamy, P ;
Goldman, L ;
Knaus, WA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (04) :959-967
[9]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[10]   COPD exacerbations 1: Epidemiology [J].
Donaldson, GC ;
Wedzicha, JA .
THORAX, 2006, 61 (02) :164-168